- Home
- MIST vs BIDU Comparison
MIST vs BIDU Comparison
Compare MIST & BIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- BIDU
- Stock Information
- Founded
- MIST 2003
- BIDU 2000
- Country
- MIST Canada
- BIDU China
- Employees
- MIST N/A
- BIDU N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- BIDU Computer Software: Programming Data Processing
- Sector
- MIST Health Care
- BIDU Technology
- Exchange
- MIST Nasdaq
- BIDU Nasdaq
- Market Cap
- MIST 53.9M
- BIDU 28.5B
- IPO Year
- MIST N/A
- BIDU 2005
- Fundamental
- Price
- MIST $1.12
- BIDU $87.06
- Analyst Decision
- MIST Strong Buy
- BIDU Buy
- Analyst Count
- MIST 2
- BIDU 11
- Target Price
- MIST $9.50
- BIDU $116.09
- AVG Volume (30 Days)
- MIST 1.6M
- BIDU 3.0M
- Earning Date
- MIST 05-20-2025
- BIDU 05-21-2025
- Dividend Yield
- MIST N/A
- BIDU N/A
- EPS Growth
- MIST N/A
- BIDU 19.61
- EPS
- MIST N/A
- BIDU 9.04
- Revenue
- MIST N/A
- BIDU $18,238,549,935.00
- Revenue This Year
- MIST N/A
- BIDU $5.00
- Revenue Next Year
- MIST N/A
- BIDU $5.88
- P/E Ratio
- MIST N/A
- BIDU $9.70
- Revenue Growth
- MIST N/A
- BIDU N/A
- 52 Week Low
- MIST $0.63
- BIDU $74.71
- 52 Week High
- MIST $2.75
- BIDU $116.25
- Technical
- Relative Strength Index (RSI)
- MIST 46.48
- BIDU 50.27
- Support Level
- MIST $1.28
- BIDU $85.88
- Resistance Level
- MIST $1.32
- BIDU $92.22
- Average True Range (ATR)
- MIST 0.12
- BIDU 1.88
- MACD
- MIST 0.03
- BIDU 0.26
- Stochastic Oscillator
- MIST 38.80
- BIDU 52.91
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.